Stay updated on Daratumumab in NKTCL Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in NKTCL Clinical Trial page.

Latest updates to the Daratumumab in NKTCL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page footer now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.1%

- Check25 days agoChange DetectedPublication notes were updated to indicate automatic filling from PubMed. The revision version information was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check32 days agoChange DetectedRemoved the government funding lapse notice (informational banner about operating status) from the page; this non-critical banner does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange DetectedThe new screenshot reflects minor UI adjustments such as spacing and header alignment, with no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedThe page now shows the new revision v3.2.0 and removes the old v3.0.2. This is an update to the release/version information.SummaryDifference0.1%

- Check77 days agoChange DetectedVersion bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in NKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in NKTCL Clinical Trial page.